Gov’t won’t appeal ruling on graphic cigarette warnings 
Published: April 1, 2013
Tags: cigarettes, Department of Justice, DOJ, FDA, First Amendment, Food and Drug Administration, Liggett Group, Lorillard, R.J. Reynolds, tobacco labeling
The Department of Justice has decided not to appeal a court decision striking down the Food and Drug Administration’s new graphic warnings on cigarette packages on First Amendment grounds.
FDA issues new warning for anti-bacterial drug
By:
Correy E. Stephenson and Steve Lash
Published: March 22, 2013
Tags: FDA, Food and Drug Administration, Pfizer, Z-Pak, Zithromax
In light of recent studies, the Food and Drug Administration cautioned that azithromycin, a drug used to treat bacterial infections, can cause abnormal and even fatal heart rhythms.
FDA issues guidance on ‘latex-free’ medical supplies
Published: March 13, 2013
Tags: Food and Drug Administration, latex, medical supplies
WASHINGTON – The Food and Drug Administration has proposed new rules for labeling medical products that are not made with latex.
Mass. jury awards $63M for child’s reaction to Motrin
By:
Correy Stephenson
Published: March 1, 2013
Tags: Children’s Motrin, consumer protection, drug litigation, failure to warn, FDA, Food and Drug Administration, Johnson & Johnson, Motrin, preemption, Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis
A Massachusetts jury awarded $63 million to a teenaged girl and her parents after the girl suffered an adverse reaction to Children’s Motrin that left her scarred and blind, with permanent brain and lung damage.
And the award may increase.
Propecia’s sexual side effects may be ‘irreversible,’ report says
Published: February 7, 2013
Tags: ADHD, Daytrana, drug litigation, FDA, Food and Drug Administration, Institute for Safe Medication Practices, multidistrict litigation, Noven Therapeutics, product liability, Propecia, Proscar, QuarterWatch
Sexual side effects experienced by men taking the hair-loss drug Propecia may be permanent, according to a new report by a drug industry watchdog.
8th Circuit blocks federal contraception mandate
Published: February 4, 2013
Tags: Affordable Care Act, contraception, contraceptive mandate, Department of Health and Human Services, FDA, Food and Drug Administration, health care reform, HHS, Obamacare, Patient Protection and Affordable Care Act, Religious Freedom Restoration Act
The new federal requirement that all group health plans must include coverage for FDA-approved contraceptive methods probably violates the religious rights of an employer who is a devout Catholic, the 8th Circuit has ruled in granting a preliminary injunction.
Report: Over 80 deaths tied to da Vinci robot surgery
Published: February 1, 2013
Tags: Citron Research, da Vinci robot, FDA, Food and Drug Administration, Intuitive Surgical, product liability, robotic surgery
There have been more than 80 deaths and thousands of injuries involving patients who underwent procedures with the da Vinci surgical robot, according to a new analysis of Food and Drug Administration adverse event reports.
Medtronic pain pump claim isn’t preempted
Published: January 15, 2013
Tags: failure to warn, FDA, Food and Drug Administration, Medical Device Amendments to the Food Drug and Cosmetic Act, Medtronic, preemption, product liability
Federal law does not preempt a state failure-to-warn lawsuit brought by a man who claimed he suffered paralysis as the result of the surgical implantation of a Medtronic pain pump, the en banc 9th Circuit has ruled.
The decision overturns a contrary panel ruling. (See “» Continue Reading.
FDA offers sweeping rules to prevent foodborne illness
Published: January 10, 2013
Tags: Food and Drug Administration, food safety, foodborne illness, regulations
WASHINGTON – The Food and Drug Administration has proposed a set of sweeping rules designed to boost the agency’s ability to root out the causes of foodborne illness rather than merely respond to outbreaks after they occur.
Class action alleges deceptive marketing of Monster Energy drinks
Published: January 9, 2013
Tags: class actions, consumer protection, deceptive marketing, ENERGY DRINKS, failure to warn, FDA, Food and Drug Administration, Magnuson-Moss Warranty Act, Monster Energy
Monster-brand energy drinks are marketed as being conventional carbonated beverages despite containing “dangerously high” amounts of caffeine, according to a new consumer class action filed in California federal court.
